University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Stefanie Ueda, M.D.

Gynecologic cancer surgeon

Dr. Stefanie M. Ueda specializes in gynecologic cancers, with a particular interest in ovarian cancer and robotic surgery. Her research has addressed conditions and treatments including low grade serous and clear cell ovarian cancer, uterine serous cancer, biologically targeted therapies and clinical treatment outcomes.

Ueda earned a medical degree with honors from the New York University School of Medicine. She completed a residency in obstetrics and gynecology at the University of Hawaii and a fellowship at the Kelly Gynecologic Oncology Service in the Johns Hopkins School of Medicine. She received awards for cancer research in 2007 from the Hera Women's Cancer Foundation and Entertainment Industry Foundation. Ueda is a member of the Society of Gynecologic Oncologists.

Clinics

Gynecologic Surgical Oncology
1600 Divisadero St., Fourth Floor
San Francisco, CA 94115
Phone: (415) 353-9600
New Patient Fax: (415) 885-7662

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Stefanie Ueda

Education

New York University School of Medicine 2002

Residencies

University of Hawaii Hospital, Obstetrics & Gynecology 2006

Fellowships

John Hopkins Hospital, Gynecological Oncology

Selected Research and Publications

  1. Fader AN, Java J, Ueda S, Bristow RE, Armstrong DK, Bookman MA, Gershenson DM. Survival in women with grade 1 serous ovarian carcinoma. Obstet Gynecol. 2013 Aug; 122(2 Pt 1):225-32.
  2. Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013 May; 107(6):653-8.
  3. Amanam I, Kiet T, Young-Lin N, Chen L, Brooks R, Ueda S, Monk B, Kapp D, Hoth D, Chan J. Applications for oncologic drugs - Lessons from the oncologic drug advisory committee. Gynecol Oncol. 2012 Oct; 127(1 Suppl):S13.
  4. Simons E, Kiet T, Amanam I, Chen L, Brooks R, Ueda S, Kapp D, Chan J. Improved outcomes of younger compared to older ovarian cancer patients - What is the role of immune regulation? Gynecol Oncol. 2012 Oct; 127(1 Suppl):S14-5.
  5. Amanam I, Kiet T, Young-Lin N, Chen L, Brooks R, Ueda S, Monk B, Kapp D, Hoth D, Chan J. Trends and progress of oncology drug development - An analysis of the FDA oncologic drug advisory committee reviews. Gynecol Oncol. 2012 Oct; 127(1 Suppl):S11-2.
  6. Harris K, Kiet T, Amanam I, Chen L, Brooks R, Ueda S, Kapp D, Chan J. The potential role of immune regulation in the presentation of early vs. advanced ovarian cancer. Gynecol Oncol. 2012 Oct; 127(1 Suppl):S14.
  7. Amanam I, Kiet T, Young-Lin N, Chen L, Brooks R, Ueda S, Monk B, Kapp D, Hoth D, Chan J. Predictive model for cancer drug approval - An analysis of FDA drug submissions over the last decade. Gynecol Oncol. 2012 Oct; 127(1 Suppl):S13-4.
  8. Ruskin R, Kiet T, Amanam I, Chen L, Brooks R, Ueda S, Kapp D, Chan J. Differences in tumor immune regulation between African-American and Caucasian ovarian cancer patients. Gynecol Oncol. 2012 Oct; 127(1 Suppl):S14.
  9. Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting. Gynecol Oncol. 2013 Jan; 128(1):128-31.
  10. Giuntoli RL, Gerardi MA, Yemelyanova AV, Ueda SM, Fleury AC, Diaz-Montes TP, Bristow RE. Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival. Int J Gynecol Cancer. 2012 Feb; 22(2):273-9.
  11. Bristow RE, Ueda S, Gerardi MA, Ajiboye OB, Ibeanu OA. Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center. Gynecol Oncol. 2011 Aug; 122(2):319-23.
  12. Skaznik-Wikiel ME, Ueda SM, Frasure HE, Rose PG, Fleury A, Grumbine FC, Fader AN. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype? Acta Cytol. 2011; 55(3):255-60.
  13. Krill LS, Ueda SM, Gerardi M, Bristow RE. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers. Gynecol Oncol. 2011 Feb; 120(2):220-3.
  14. Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, Visvanathan K, Kuhajda FP, Bristow RE, Zhang H, Shih IeM. Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas. J Oncol. 2010; 2010:285191.
  15. Ueda SM, Mao TL, Kuhajda FP, Vasoontara C, Giuntoli RL, Bristow RE, Kurman RJ, Shih IeM. Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. Am J Pathol. 2009 Dec; 175(6):2618-24.
  16. Barlin JN, Ueda SM, Bristow RE. Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature. Womens Health (Lond Engl). 2009 Jul; 5(4):403-11.
  17. Veras E, Mao TL, Ayhan A, Ueda S, Lai H, Hayran M, Shih IeM, Kurman RJ. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol. 2009 Jun; 33(6):844-53.
  18. Bristow RE, Peiretti M, Gerardi M, Zanagnolo V, Ueda S, Diaz-Montes T, Giuntoli RL, Maggioni A. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome. Gynecol Oncol. 2009 Aug; 114(2):173-7.
  19. Chan JK, Ueda SM, Sugiyama VE, Stave CD, Shin JY, Monk BJ, Sikic BI, Osann K, Kapp DS. Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? J Clin Oncol. 2008 Mar 20; 26(9):1511-8.
  20. Ueda SM, Kapp DS, Cheung MK, Shin JY, Osann K, Husain A, Teng NN, Berek JS, Chan JK. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008 Feb; 198(2):218.e1-6.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.